| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Nick Craddock | Q18685542 |
| Michael C O'Donovan | Q30410265 | ||
| P2093 | author name string | Owen MJ | |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 518-525 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Trends in Genetics | Q2451468 |
| P1476 | title | Schizophrenia: genes at last? | |
| P478 | volume | 21 |
| Q34957463 | A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. |
| Q44395308 | A genome-wide association study for quantitative traits in schizophrenia in China. |
| Q33406258 | A genome-wide investigation of SNPs and CNVs in schizophrenia |
| Q36665096 | A public health genetic approach for schizophrenia |
| Q48638124 | A resting-state functional magnetic resonance imaging study on the first-degree relatives of persons with schizophrenia |
| Q30678998 | A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia |
| Q51734733 | Abnormal social behaviors in mice lacking Fgf17. |
| Q33717636 | Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice. |
| Q34246745 | AlexSys: a knowledge-based expert system for multiple sequence alignment construction and analysis |
| Q48268990 | Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. |
| Q37249390 | Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling |
| Q30545900 | Analysis of TBX1 variation in patients with psychotic and affective disorders |
| Q35221473 | Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia |
| Q37714955 | Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development |
| Q35644834 | Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population |
| Q47141045 | Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population |
| Q31117742 | Association of NKAPL, TSPAN18, and MPC2 gene variants with schizophrenia based on new data and a meta-analysis in Han Chinese |
| Q35891516 | Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies |
| Q40656372 | Association of common variants in H2AFZ gene with schizophrenia and cognitive function in patients with schizophrenia. |
| Q54189502 | Association of schizophrenia with T102C (rs6313) and 1438 A/G (rs6311) polymorphisms of HTR2A gene. |
| Q28300667 | Association of the NRG1 gene and schizophrenia: a meta-analysis |
| Q34656692 | Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. |
| Q28567313 | BLOC-1 complex deficiency alters the targeting of adaptor protein complex-3 cargoes |
| Q48362489 | Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice |
| Q42773108 | Breaking the gene barrier in schizophrenia |
| Q51901247 | CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. |
| Q36392547 | Can RGS4 polymorphisms be viewed as credible risk factors for schizophrenia? A critical review of the evidence |
| Q37461063 | Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? |
| Q36792147 | Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness |
| Q48434318 | Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia |
| Q28308288 | Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer |
| Q40689016 | Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. |
| Q31139562 | Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. |
| Q41312111 | Common variants of HTR1A and SLC6A4 confer the increasing risk of Schizophrenia susceptibility: A population-based association and epistasis analysis |
| Q36909124 | Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q24670103 | Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia |
| Q51020187 | D-serine treatment induces oxidative stress in rat brain. |
| Q30435763 | Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders |
| Q51868690 | Disrupted-in-Schizophrenia-1 (Disc1) is necessary for migration of the pyramidal neurons during mouse hippocampal development. |
| Q48332729 | Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? |
| Q36881176 | Dopamine genes and schizophrenia: case closed or evidence pending? |
| Q38177357 | Drug discovery based on genetic and metabolic findings in schizophrenia |
| Q33506534 | Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects |
| Q89860147 | Effects of Cannabis Use on the Protein and Lipid Profile of Olfactory Neuroepithelium Cells from Schizophrenia Patients Studied by Synchrotron-Based FTIR Spectroscopy |
| Q58462446 | Effects of DTNBP1 genotype on brain development in children |
| Q28082318 | Evaluating historical candidate genes for schizophrenia |
| Q36996747 | Exploring genetic counselors' perceptions of and attitudes towards schizophrenia |
| Q33846487 | Expression of synemin in the mouse spinal cord |
| Q36304346 | Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. |
| Q37723316 | Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population |
| Q37714958 | Gene manipulation with stereotaxic viral infection for psychiatric research: spatiotemporal components for schizophrenia |
| Q35173614 | Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia |
| Q37108117 | Genetic and environmental factors in complex neurodevelopmental disorders |
| Q35828401 | Genetic influences on the development of childhood psychiatric disorders |
| Q37019823 | Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance |
| Q22252693 | Genetics of psychosis; insights from views across the genome |
| Q34747276 | Genome-Wide Linkage Scan of Bipolar Disorder in a Colombian Population Isolate Replicates Loci on Chromosomes 7p21–22, 1p31, 16p12 and 21q21–22 and Identifies a Novel Locus on Chromosome 12q |
| Q33382735 | Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum |
| Q37095356 | Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review |
| Q30991988 | Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia |
| Q36082300 | Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence |
| Q36750242 | Implications for neurobiological research of cognitive models of psychosis: a theoretical paper |
| Q36489534 | In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors |
| Q21203806 | Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia |
| Q59668329 | Interactions gènes/environnement dans la schizophrénie |
| Q80733897 | Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? |
| Q37140379 | Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition |
| Q36756393 | Involvement of neuropeptide systems in schizophrenia: human studies |
| Q36782538 | Is COMT a susceptibility gene for schizophrenia? |
| Q30475728 | Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits |
| Q37290557 | Linkage analysis of schizophrenia in African-American families |
| Q37076213 | Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia |
| Q37192367 | Methionine sulfoxide reductase: a novel schizophrenia candidate gene |
| Q42523654 | Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. |
| Q37275670 | Modulation of D-serine levels in brains of mice lacking PICK1 |
| Q35925744 | Molecular mechanisms involved in depotentiation and their relevance to schizophrenia |
| Q92649238 | NMDAR Hypofunction Animal Models of Schizophrenia |
| Q37309811 | Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome |
| Q37096511 | Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models |
| Q37588242 | Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. |
| Q37374232 | New findings from genetic association studies of schizophrenia |
| Q46660680 | No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes. |
| Q24301877 | Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression |
| Q54354559 | OPCML gene as a schizophrenia susceptibility locus in Thai population. |
| Q47072586 | Phenotypes of Drosophila brain neurons in primary culture reveal a role for fascin in neurite shape and trajectory. |
| Q30490136 | Physiogenomic analysis of localized FMRI brain activity in schizophrenia |
| Q33635801 | Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. |
| Q90289789 | Psychosocial Stress Induces Schizophrenia-Like Behavior in Mice With Reduced MMP-9 Activity |
| Q37765631 | REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. |
| Q28239852 | Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families |
| Q61654770 | Rethinking schizophrenia through the lens of evolution: shedding light on the enigma |
| Q30476810 | Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models |
| Q33819217 | SZGR: a comprehensive schizophrenia gene resource |
| Q56061326 | Schizophrenia and Other Psychoses |
| Q37401357 | Schizophrenia and epilepsy: is there a shared susceptibility? |
| Q37483078 | Schizophrenia genetics: new insights from new approaches |
| Q24625434 | Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila |
| Q35144224 | Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis |
| Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
| Q41871244 | Schizophrenia: a consequence of gene-environment interactions? |
| Q35909867 | Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes. |
| Q30370232 | Schizophrenia: complex genetics, not fairy tales. |
| Q91959868 | Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model |
| Q28285397 | Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database |
| Q37288594 | The Association between COMT, BDNF, and NRG1 and Premorbid Social Functioning in Patients with Psychosis, Their Relatives, and Controls |
| Q36652587 | The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes |
| Q28265950 | The NPAS3 gene--emerging evidence for a role in psychiatric illness |
| Q38791515 | The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects. |
| Q33374175 | The changing impact of genes and environment on brain development during childhood and adolescence: initial findings from a neuroimaging study of pediatric twins |
| Q81114875 | The emperors of the schizophrenia polygene have no clothes |
| Q34501825 | The molecular genetic architecture of human personality: beyond self-report questionnaires |
| Q33344726 | The myelin-pathogenesis puzzle in schizophrenia: a literature review |
| Q34217470 | The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits |
| Q24658343 | The neurodevelopmental hypothesis of schizophrenia, revisited |
| Q24656574 | The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease |
| Q24629562 | The neuropsychopharmacology of fronto-executive function: monoaminergic modulation |
| Q35858246 | The schizophrenic faces of PICK1. |
| Q34658426 | Trait components provide tools to dissect the genetic susceptibility of migraine |
| Q28306713 | Update on psychiatric genetics |
| Q37159625 | What we know: findings that every theory of schizophrenia should explain. |
| Q37402422 | Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia |
| Q43187398 | mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage. |
Search more.